The following is a summary of “Risk prediction modeling for cardiorenal clinical outcomes in patients with non-diabetic CKD ...
Patients with advanced chronic kidney disease, particularly those on maintenance hemodialysis, may have reduced perception of smell, according to published data.“The olfactory sensory system processes ...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
Fish delivers protein, and when you choose a fatty fish like tuna, salmon or trout, you're also getting omega-3 fatty acids.
In India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies ...
Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report) and keeping the price target at ...
No randomized clinical trials have directly compared empagliflozin with dapagliflozin for type 2 diabetes, so investigators conducted a large comparative effectiveness study examining kidney outcomes.
PReconditioning IMmunostimulatory Evaluation – Phase 1b clinical study of escalating doses of intravenously administered Gemini in patients with Stage 3 and 4 Chronic Kidney Disease, or CKD. The US ...